Heart Failure pp 209-218 | Cite as

β-Adrenergic Receptor Desensitization in Cardiac Disease: Insights from Gene-Targeted Mice

  • Dong-Ju Choi
  • Walter J. Koch
  • Howard A. Rockman
Conference paper


β-Adrenergic receptors (βARS) belong to the large family of G-protein-coupled receptors that form the interface between the sympathetic nervous system and the cardiovascular system. Binding of β-agonists to the βAR leads to activation of adenylyl cyclase, generating cAMP and activating cAMP-dependent protein kinase A (PKA). Phosphorylation of critical regulatory proteins by PKA acts in concert to increase the rate of contraction, peak force, and the rate of relaxation. The regulation of myocardial βARS involves a process characterized by a rapid loss of receptor responsiveness despite continued presence of agonist. Chronic human heart failure is characterized by marked βAR receptor desensitization as the result of both diminished βAR number (receptor downregulation) and impaired βAR function (receptor uncoupling). This review focuses on some recent studies using gene-targeted mouse models to understand the role of the βAR system in pathological conditions of cardiac hypertrophy and heart failure.

Key words

βAR receptor desensitization Cardiac hypertrophy Heart failure Gene-targeted mouse models 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ji TH, Grossmann M, Ji I (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273: 17299-17302PubMedCrossRefGoogle Scholar
  2. 2.
    Gether U, Kobilka BK (1998) G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273: 17979-17982PubMedCrossRefGoogle Scholar
  3. 3.
    Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63: 101 - 132PubMedCrossRefGoogle Scholar
  4. 4.
    Lefkowitz RJ (1993) G protein-coupled receptor kinases. Cell 74: 409 - 412PubMedCrossRefGoogle Scholar
  5. 5.
    Lefkowitz RI (1998) G protein-coupled receptors. III. New roles for receptor kinases and (3-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677 - 18680PubMedCrossRefGoogle Scholar
  6. 6.
    Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67: 653 - 692PubMedCrossRefGoogle Scholar
  7. 7.
    Lohse MJ, Krasel C, Winstel R, Mayor F Jr (1996) G-protein-coupled receptor kinases. Kidney Int 49: 1047 - 1052PubMedCrossRefGoogle Scholar
  8. 8.
    Lohse MJ (1993) Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179: 171 - 188PubMedCrossRefGoogle Scholar
  9. 9.
    Hausdorff WP, Caron MG, Lefkowitz RJ (1990) Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 4: 2881 - 2889PubMedGoogle Scholar
  10. 10.
    Freedman NJ, Liggett SB, Drachman DE, Pei G, Caron MG, Lefkowitz RJ (1995) Phosphorylation and desensitization of the human beta,-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem 270: 17953-17961PubMedCrossRefGoogle Scholar
  11. 11.
    Fredericks ZL, Pitcher JA, Lefkowitz RJ (1996) Identification of the G protein-coupled receptor kinase phosphorylation sites in the human betaZ adrenergic receptor. J Biol Chem 271: 13796 - 13803PubMedCrossRefGoogle Scholar
  12. 12.
    Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ (1993) Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem 268: 23735 - 23738PubMedGoogle Scholar
  13. 13.
    Rockman HA, Koch WJ, Lefkowitz RJ (1997) Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am J Physiol 272: H1553 - H1559PubMedGoogle Scholar
  14. 14.
    Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ (1992) Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 257: 1264 - 1267PubMedCrossRefGoogle Scholar
  15. 15.
    Koch WJ, Inglese J, Stone WC, Lefkowitz RJ (1993) The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem 268: 8256 - 8260PubMedGoogle Scholar
  16. 16.
    Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) ß-arrestin: a protein that regulates ß-adrenergic receptor function. Science 248: 1547 - 1550PubMedCrossRefGoogle Scholar
  17. 17.
    Clapham DE, Neer EJ (1993) New roles for G-protein beta gamma-dimers in trans-membrane signalling. Nature (Lond) 365: 403 - 406CrossRefGoogle Scholar
  18. 18.
    Nair LA, Inglese J, Stoffel R, Koch WJ, Lefkowitz RJ, Kwatra MM, Grant AO (1995) Cardiac muscarinic potassium channel activity is attenuated by inhibitors of G beta gamma. Circ Res 76: 832 - 838PubMedGoogle Scholar
  19. 19.
    Tang WJ, Gilman AG (1991) Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 254: 1500 - 1503PubMedCrossRefGoogle Scholar
  20. 20.
    Grossman W, Jones D, McLaurin LP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56 - 64PubMedCrossRefGoogle Scholar
  21. 21.
    Lorell BH (1997) Transition from hypertrophy to failure. Circulation 96: 3824 - 3827PubMedGoogle Scholar
  22. 22.
    Eichhorn EJ, Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94: 2285-2296PubMedGoogle Scholar
  23. 23.
    Force T, Bonventre JV (1998) growth factors and mitogen activated protein kinases. Hypertension 31: 152 - 161Google Scholar
  24. 24.
    Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800 - 806PubMedCrossRefGoogle Scholar
  25. 25.
    Post GR, Brown JH (1996) G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10: 741 - 749PubMedGoogle Scholar
  26. 26.
    D’Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GWN (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121 - 8126PubMedCrossRefGoogle Scholar
  27. 27.
    Sakata Y, Hoit BD, Liggett SB, Walsh RA, Dorn GWI (1998) Decompensation of pressure-overload hypertrophy in Gaq-overexpressing mice. Circulation 97: 14881495Google Scholar
  28. 28.
    Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ (1998) Targeting the receptor-G(q) interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280: 574 - 577PubMedCrossRefGoogle Scholar
  29. 29.
    Bohm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M, Erdmann E (1994) Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension 24: 653 - 662PubMedGoogle Scholar
  30. 30.
    Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88: 8277 - 8281PubMedCrossRefGoogle Scholar
  31. 31.
    Rockman HA, Knowlton KU, Ross J Jr, Chien KR (1993) In vivo murine cardiac hypertrophy. A novel model to identify genetic signaling mechanisms that activate an adaptive physiological response. Circulation 87:VII-14-VII-21Google Scholar
  32. 32.
    Choi DJ, Koch WJ, Hunter JJ, Rockman HA (1997) Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem 272: 17223 - 17229PubMedCrossRefGoogle Scholar
  33. 33.
    Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268: 1350 - 1353PubMedCrossRefGoogle Scholar
  34. 34.
    Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913 - 919PubMedCrossRefGoogle Scholar
  35. 35.
    Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819 - 823PubMedCrossRefGoogle Scholar
  36. 36.
    Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction ( SOLVD ). Circulation 82: 1724-1729PubMedCrossRefGoogle Scholar
  37. 37.
    Rockman HA, Juneau C, Chatterjee K, Rouleau JL (1989) Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 64: 1344 - 1348PubMedCrossRefGoogle Scholar
  38. 38.
    Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205 - 211PubMedCrossRefGoogle Scholar
  39. 39.
    Feldman AM (1993) Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 87:IV-27-IV-34Google Scholar
  40. 40.
    Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E, Lohse MJ (1994) Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 74: 206 - 213PubMedGoogle Scholar
  41. 41.
    Gros R, Benovic JL, Tan CM, Feldman RD (1997) G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 99: 2087 - 2093PubMedCrossRefGoogle Scholar
  42. 42.
    Ungerer M, Kessebohm K, Kronsbein K, Lohse MJ, Richardt G (1996) Activation of beta-adrenergic receptor kinase during myocardial ischemia. Cire Res 79: 455 - 460Google Scholar
  43. 43.
    Brodde OE (1993) Beta-adrenoceptors in cardiac disease. Pharmacol Ther 60: 405 - 430PubMedCrossRefGoogle Scholar
  44. 44.
    Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta-1 -adrenergicreceptors in the failing human heart. Circulation 87: 451 163Google Scholar
  45. 45.
    Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, Koch WJ (1996) Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci USA 93: 9954 - 9959PubMedCrossRefGoogle Scholar
  46. 46.
    Ping P, Gelzer-Bell R, Roth DA, Kiel D, Insel PA, Hammond HK (1995) Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart. J Clin Invest 95: 1271 - 1280PubMedCrossRefGoogle Scholar
  47. 47.
    Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ (1998) Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by (3-adrenergic receptor stimulation and blockade. Circulation 98: 1783 - 1789PubMedGoogle Scholar
  48. 48.
    Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334: 1349-1355PubMedCrossRefGoogle Scholar
  49. 49.
    Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, Lefkowitz RJ, Caron MG, Koch WJ (1998) Control of myocardial contractile function by the level of ß-adrenergic receptor kinase-1 in gene-targeted mice. J Biol Chem 273: 18180 - 18184PubMedCrossRefGoogle Scholar
  50. 50.
    Jaber M, Koch WJ, Rockman HA, Smith B, Bond RA, Sulik K, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B (1996) Essential role of beta-adrenergic receptor kinase-1 in cardiac development and function. Proc Natl Acad Sci USA 93: 12974 - 12979PubMedCrossRefGoogle Scholar
  51. 51.
    Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ (1998) Expression of a ß-adrenergic receptor kinase-1 inhibitor prevents the development of heart failure in gene-targeted mice. Proc Natl Acad Sci USA 95: 7000 - 7005PubMedCrossRefGoogle Scholar
  52. 52.
    Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ (1994) Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264: 582 - 586PubMedCrossRefGoogle Scholar
  53. 53.
    Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard J-C, Chien KR, Caroni P (1997) MLP-deficient mice exhibit a disruption of cardiac cytoarchitecture organization, dilated cardiomyopathy, and heart failure. Cell 88: 393 - 403PubMedCrossRefGoogle Scholar
  54. 54.
    Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325: 1468-1475PubMedCrossRefGoogle Scholar
  55. 55.
    Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schafer E, Hakim K, Zerkowski HR (1998) Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31: 585 - 594PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2000

Authors and Affiliations

  • Dong-Ju Choi
    • 1
  • Walter J. Koch
    • 2
  • Howard A. Rockman
    • 3
  1. 1.Department of Medicine and Cardiovascular Research InstituteGyeong-Sang National UniversityChinjuKorea
  2. 2.Department of SurgeryDuke UniversityDurhamUSA
  3. 3.Department of MedicineDuke UniversityDurhamUSA

Personalised recommendations